February 11, 2016 review IgA nephropathy Nature Reviews Disease Primers DOI: 10.1038/nrdp.2016.1 OpenAlex Authors 0 Author list not loaded yet. Cited by 14 stored of 517 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Complement-Mediated Kidney Diseases: Role of Alternative Pathway in Glomerular Inflammation 2025 Kidney International Reports article Immunology and Microbiology Complement system in diseases Open access 3 citations A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy 2025 New England Journal of Medicine article Medicine Renal Diseases and Glomerulopathies 51 citations Neutrophil-derived LL37 mediates IgA nephropathy via NETs-dependent mechanism 2025 Research Square preprint Medicine Renal Diseases and Glomerulopathies Open access 0 citations The journey of patients with musculoskeletal complaints in Europe: a cross-sectional European survey 2025 Rheumatology International article Medicine Musculoskeletal pain and rehabilitation Open access 1 citations Comprehensive Immunoglobulin G, A, and M Glycopeptide Profiling for Large-Scale Biomedical Research 2025 Molecular & Cellular Proteomics article Biochemistry, Genetics and Molecular Biology Glycosylation and Glycoproteins Research Open access 10 citations Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy 2024 Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies Open access 61 citations A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy 2024 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access 137 citations GlYcoLISA: antigen-specific and subclass-specific IgG Fc glycosylation analysis based on an immunosorbent assay with an LC–MS readout 2024 Nature Protocols article Biochemistry, Genetics and Molecular Biology Glycosylation and Glycoproteins Research Open access 34 citations IgA nephropathy 2023 Nature Reviews Disease Primers review Medicine Renal Diseases and Glomerulopathies Open access 246 citations Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial 2023 The Lancet article Medicine Renal Diseases and Glomerulopathies Open access 334 citations A Focus Group Study of Self-Management in Patients With Glomerular Disease 2021 Kidney International Reports article Medicine Dialysis and Renal Disease Management Open access 7 citations Current treatment of IgA nephropathy 2021 Seminars in Immunopathology article Medicine Renal Diseases and Glomerulopathies Open access cited by 1 patent 149 citations Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease 2021 Kidney International article Social Sciences Delphi Technique in Research Open access 12 citations How will artificial intelligence and bioinformatics change our understanding of IgA Nephropathy in the next decade? 2021 Seminars in Immunopathology article Medicine Renal Diseases and Glomerulopathies Open access 28 citations 14 results References 0